Deficit of circulating stem--progenitor cells in opiate addiction: a pilot study

Area of Science:

• Addiction research
• Toxicology
• Aging

Background:

• Addictive drugs are known to impede cell growth and promote apoptosis.
• Previous research indicates a link between substance use disorder and accelerated aging.
• The impact of addiction on stem cell populations requires further investigation.

Purpose of the Study:

• To compare hematopoietic stem cells (HSCs) and endothelial progenitor cells (EPCs) in opiate-dependent patients versus non-addicted individuals.
• To investigate the potential role of stem cell depletion in addiction-related aging.
• To assess the implications for understanding addiction toxicology and treatment.

Main Methods:

• Flow cytometry was used to analyze peripheral blood samples.
• CD34(+) CD45(+) cells were quantified as HSCs.
• CD34(+) KDR(+) (VEGFR2(+)) cells were quantified as EPCs in 10 patients with substance use disorder (SUD) and 11 non-SUD controls.

Main Results:

• No significant difference was observed in HSC counts between SUD and non-SUD groups.
• EPC counts were significantly lower in the SUD group compared to the non-SUD group (0.09 vs. 0.26 cells/mcl).
• This reduction in EPCs was observed despite the SUD group being significantly younger than the non-SUD group.

Conclusions:

• Reduced EPCs in opiate-dependent individuals suggest accelerated aging.
• Stem cell pool alterations are implicated in addiction toxicology and aging processes.
• The toxicity of addiction and long-term agonist therapies may be underestimated, necessitating policy review.